latest news releases from the newsroom
Trigen's Novel Oral Anti-Coagulant, TGN 167, Successfully Completes Phase I Study
LONDON, Dec. 16, 2003 (PRIMEZONE) -- Trigen Ltd today announced the successful completion of a Phase I dose escalation study for its highly selective oral direct thrombin inhibitor (DTI), TGN 167, which is being developed for the prevention and treatment of thrombosis. Trigen is developing TGN 167 for safe, effective, predictable and convenient anti-coagulation for chronic out-patient use.
Bayer Healthcare and Galapagos in Target Discovery Collaboration
MECHELEN, Belgium, Dec. 16, 2003 (PRIMEZONE) -- Galapagos Genomics today announced a target discovery collaboration with Bayer HealthCare AG. Within the partnership, the Companies will collaborate to discover and validate novel drug targets for Bayer's disease areas. Galapagos will use its disease biology expertise in combination with its SilenceSelect(tm) and FLeXSelect(tm) target discovery collections to identify and validate drugable targets. Under the terms of the agreement, Bayer HealthCare has the exclusive right to select validated targets for drug development in return for upfront payments, research funding and milestones. Further financial terms were not disclosed.
Atna Resources Ltd.
DeLancey Resigns From Atna Board
VANCOUVER, British Columbia, Dec. 15, 2003 (PRIMEZONE) -- Atna Resources Ltd. (TSE:ATN) announces the resignation of Peter DeLancey from its Board of Directors, to take effect December 15. Mr. DeLancey is stepping down for health reasons. Peter has served Atna shareholders with distinction as President and Director from 1989 to 2000, as Chairman of the Board from 2000 to 2002, and since then as a Director and Chief Geologist. During his tenure with the company, he led its exploration team to its most important success to date: the discovery of the Wolverine massive sulphide zinc -- silver -- copper -- gold -- lead deposit in the Yukon, in which the company continues to retain a 39.5% interest.
Port of Houston Authority
Port Authority Commission Delivers Security Contract and MOU
HOUSTON, Dec. 15, 2003 (PRIMEZONE) -- The Port of Houston Authority (PHA) commission approved several recommendations involving contract awards, bids and proposals, professional services and general administrative and operational matters during its meeting on Monday, December 15 at the Lou Lawler Seafarers Center in LaPorte, Texas. Chairman Jim Edmonds presided over the meeting, which was open to the public.
Altnet Determines That BigChampagne Does Not Infringe TrueNames Patented Technology
WOODLAND HILLS, Calif., Dec. 15, 2003 (PRIMEZONE) -- Altnet, a subsidiary of Brilliant Digital Entertainment (AMEX:BDE), a leading provider of secure digital media via Internet and peer-to-peer technologies, announced today that, on the basis of information provided by BigChampagne, Altnet is satisfied that BigChampagne is not infringing any issued claim of Altnet's patents.
SecureCARE Technologies, Inc.
eClickMD, Inc. Announces Confirmation of its Reorganization Plan Effective December 15th, 2003
AUSTIN, Texas, Dec. 15, 2003 (PRIMEZONE) -- eClickMD, Inc. (OTCBB:ECMDQ), an Internet-based document exchange and eSignature company for the home healthcare industry, announced the confirmation of its Reorganization Plan effective December 15, 2003. eClickMD filed a voluntarily petition under Chapter 11 of the Bankruptcy Code on May 13, 2003 as part of its financial strategy to ease the company's debt service associated with years of high-cost technology development. The company used the period of reorganization to streamline its operational model, add a highly experienced senior management core team, and develop a national network of 45 independent sales representatives, which it expects to grow in number to over 100 in 2004.